Vimal Mehta's most recent trade in BioXcel Therapeutics Inc was a trade of 219 Common Stock done . Disclosure was reported to the exchange on June 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2025 | 219 | 4,486 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2025 | 219 | 2,189 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2025 | 163 | 4,267 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2025 | 163 | 979 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 217 | 2,408 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 217 | 4,104 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 162 | 3,887 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 162 | 1,142 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 3,500 | 31,500 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 3,500 | 61,903 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 2,610 | 13,049 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 2,610 | 58,403 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.36 per share. | 14 Dec 2024 | 2,134 | 59,605 (0%) | 0% | 0.4 | 773 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.36 per share. | 14 Dec 2024 | 983 | 60,920 (0%) | 0% | 0.4 | 358 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 3,500 | 53,648 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 3,500 | 35,000 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 2,609 | 15,657 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 2,609 | 50,148 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.69 per share. | 14 Sep 2024 | 1,150 | 51,666 (0%) | 0% | 0.7 | 794 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.69 per share. | 14 Sep 2024 | 832 | 52,816 (0%) | 0% | 0.7 | 573 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2024 | 6,250 | 6,250 | - | - | Stock Option (right to buy) | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,500 | 49,673 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,500 | 38,500 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 2,609 | 18,266 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 2,609 | 46,173 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 14 Jun 2024 | 2,134 | 47,539 (0%) | 0% | 1.3 | 2,739 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jun 2024 | 609,221 | 7,937,529 (43%) | 3% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jun 2024 | 283,123 | 283,122 (1%) | 1% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jun 2024 | 283,122 | 0 (0%) | 1% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 04 Jun 2024 | 126,014 | 7,685,501 (42%) | 0% | 1.6 | 199,619 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.63 per share. | 04 Jun 2024 | 126,014 | 7,811,515 (43%) | 0% | 1.6 | 205,516 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Jun 2024 | 120 | 120 | - | - | Call Options (obligation to sell) | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 14,000 | 42,000 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 14,000 | 48,832 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 2.62 per share. | 14 Mar 2024 | 4,439 | 43,564 (0%) | 0% | 2.6 | 11,651 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 2,610 | 20,875 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 2,610 | 34,832 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 2.62 per share. | 14 Mar 2024 | 829 | 48,003 (0%) | 0% | 2.6 | 2,172 | Common Stock |
| BioXcel Therapeutics Inc | Mehta Vimal | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 2,609 | 23,485 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 2,609 | 32,222 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2023 | 2,610 | 29,613 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2023 | 2,610 | 26,094 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 14 Jun 2023 | 30,000 | 69,903 (0%) | 0% | 0.4 | 12,300 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 30,000 | 294,000 | - | - | Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 30,000 | 324,000 | - | - | Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 14 Jun 2023 | 30,000 | 69,903 (0%) | 0% | 0.4 | 12,300 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 14 Jun 2023 | 24,987 | 44,916 (0%) | 0% | 20.0 | 499,990 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 21.41 per share. | 14 Jun 2023 | 21,988 | 47,915 (0%) | 0% | 21.4 | 470,763 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 21.90 per share. | 14 Jun 2023 | 8,012 | 39,903 (0%) | 0% | 21.9 | 175,463 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 20.90 per share. | 14 Jun 2023 | 4,266 | 40,650 (0%) | 0% | 20.9 | 89,159 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 2,609 | 39,903 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 2,609 | 28,704 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 21.89 per share. | 14 Jun 2023 | 747 | 39,903 (0%) | 0% | 21.9 | 16,352 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 25.79 per share. | 22 May 2023 | 6,500 | 37,294 (0%) | 0% | 25.8 | 167,641 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2023 | 15,000 | 30,894 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2023 | 15,000 | 0 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2023 | 30,000 | 354,000 | - | - | Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2023 | 30,000 | 384,000 | - | - | Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 20 Mar 2023 | 30,000 | 45,894 (0%) | 0% | 0.4 | 12,300 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 20 Mar 2023 | 30,000 | 50,394 (0%) | 0% | 0.4 | 12,300 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 19.70 per share. | 20 Mar 2023 | 29,100 | 16,794 (0%) | 0% | 19.7 | 573,270 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 18.20 per share. | 20 Mar 2023 | 24,667 | 25,727 (0%) | 0% | 18.2 | 448,939 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 18.86 per share. | 20 Mar 2023 | 5,333 | 20,394 (0%) | 0% | 18.9 | 100,580 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 18.22 per share. | 20 Mar 2023 | 3,896 | 16,498 (0%) | 0% | 18.2 | 70,985 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 20.15 per share. | 20 Mar 2023 | 900 | 15,894 (0%) | 0% | 20.2 | 18,135 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 18.88 per share. | 20 Mar 2023 | 604 | 15,894 (0%) | 0% | 18.9 | 11,404 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 168,000 | 168,000 | - | - | Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 56,000 | 56,000 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 10,437 | 31,313 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 10,437 | 20,394 (0%) | 0% | - | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 145,549 | 8,546,750 (47%) | 0% | 0 | Common Stock | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 15 Dec 2022 | 30,000 | 39,957 (0%) | 0% | 0.4 | 12,300 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 15 Dec 2022 | 30,000 | 39,957 (0%) | 0% | 0.4 | 12,300 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 30,000 | 414,000 | - | - | Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 30,000 | 444,000 | - | - | Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.86 per share. | 15 Dec 2022 | 22,794 | 17,163 (0%) | 0% | 19.9 | 452,689 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.21 per share. | 15 Dec 2022 | 20,113 | 19,844 (0%) | 0% | 19.2 | 386,371 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.92 per share. | 15 Dec 2022 | 9,887 | 9,957 (0%) | 0% | 19.9 | 196,949 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.19 per share. | 15 Dec 2022 | 7,206 | 9,957 (0%) | 0% | 20.2 | 145,489 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2022 | 15,000 | 15,000 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 167,000 | 167,000 | - | - | Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 41,750 | 41,750 | - | - | Restricted Stock Units | |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO, President and Secretary | Sale of securities on an exchange or to another person at price $ 30.83 per share. | 25 Jun 2021 | 473,250 | 8,546,750 (47%) | 2% | 30.8 | 14,589,493 | Common Stock |
| BioXcel Therapeutics Inc | Vimal Mehta | Director, CEO, President and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) |